Eliksa Therapeutics
Blood & Organ Banks · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3805 Old Easton Rd, Doylestown, Pennsylv...Website
www.eliksa.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Eliksa Therapeutics
Eliksa Therapeutics is a biotechnology company based in Doylestown, Pennsylvania, developing innovative therapies for Epidermolysis bullosa (EB) and related conditions. Leveraging technology licensed from the University of Utah, Eliksas lead program, ELK-003, is a biological eye drop designed to treat corneal abrasions associated with EB.Explore more
Eliksa Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Eliksa Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Eliksa Therapeutics launches new products
Earning: See what the market has to say on Eliksa Therapeutics recently announced quarterly report
Eliksa Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Eliksa Therapeutics had a recent Job posting/layoffs
Check if Eliksa Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Eliksa Therapeutics
Check out if Eliksa Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Eliksa Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Eliksa Therapeutics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Eliksa Therapeutics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Eliksa Therapeutics.
Eliksa Therapeutics Tech Stack
A closer look at the technologies used by Eliksa Therapeutics
Eliksa Therapeutics News & Media
Read more news
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding Eliksa Therapeutics
Sign Up For FreeTo access detailed company insights
Eliksa Therapeutics is a biotechnology company based in Doylestown, Pennsylvania, developing innovative therapies for Epidermolysis bullosa (EB) and related conditions. Leveraging technology licensed from the University of Utah, Eliksas lead program, ELK-003, is a biological eye drop designed to treat corneal abrasions associated with EB.... Read More
